Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: TAKARA BIO USA, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-03-29 to 2023-03-31
Current total value of award: $24900
Description: EXECUTIVE ORDER 14042 - TAKARA BIO USA, INC.:1109645 [22-002230] - ACQUISITION OF A SERVICE MAINTENANCE CONTRACT FOR THE THE ICELL8 CX AUTOMATED HIGH THROUGHPUT PLATFORM TO ISOLATE SINGLE CELLS TO CONTINUE PERFORMING SINGLE-CELL RNA-SEQ THAT IS AN EM